Industry Channel

How did the Treatable Traits approach develop?

How did the Treatable Traits approach develop?

Limited Access

Please log in to myERS to view this content

Log in

Don't have a myERS account? Register here

Note: patients and members of the public are not permitted to view this content

Limited Access

Please log in to myERS to view this content

Log in

Don't have a myERS account? Register here

Note: patients and members of the public are not permitted to view this content

GSK


This content has been provided by GSK. The content is not influenced or endorsed by the European Respiratory Society

In this episode of the Treatable Traits podcast series, Professor Alvar Agusti (Barcelona, Spain) and Dr Dave Leather (GSK, UK) provide an introduction to Treatable Traits and explain how the model of care developed. They will discuss the thinking behind this approach and what Treatable Traits means in the context of obstructive airways diseases. The conversation will then focus on the clinical benefits of a personalised approach.